Potential role of the neuropeptide CGRP in the induction of differentiation of rat hepatic portal vein wall.
The media of the rat hepatic portal vein is composed of an internal circular muscular layer (CL) and an external longitudinal muscular layer (LL). These two perpendicular layers differentiate progressively from mesenchymal cells within the first month after birth. In this paper, we studied the development of calcitonin gene-related peptide (CGRP) innervation during post-natal differentiation of the vessel. We show that CGRP innervation is already present around the vessel at birth in the future adventitia but far from the lumen of the vessel. Progressively, CGRP immunoreactive fibers reached first LL then CL. CL by itself become only innervated at day 14 after birth. This corresponds to the time at which thick filaments (myosin) are visible in electron microscopy and desmin visualisable by immunocytochemistry. Furthermore, we provide evidence by autoradiography, that binding sites for CGRP are transiently expressed on the portal vein media at day 1 and 14 after birth. Vascular smooth muscle cells were transfected with constructs containing promoters for desmin or smooth muscle myosin heavy chain (smMHC). CGRP treatment of the cells significantly increased the expression of smMHC. Overall these results suggest that CGRP can potentially influence the differentiation of smooth muscle cells from the vessel wall.
Thiévent
A
A
Université de Bourgogne, Biologie Animale Cellulaire et Moléculaire, LPPCE, IFR 100, 6 Bvd. Gabriel, 21000 Dijon, France.
Sena
S
S
Parlakian
A
A
Breuzard
G
G
Beley
A
A
Rochette
L
L
Connat
J L
JL
D000367:Age Factors; D000818:Animals; D001665:Binding Sites; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis / Q000494:pharmacology / Q000502:physiology*; D002454:Cell Differentiation / Q000502:physiology*; D002460:Cell Line; D003238:Connective Tissue / Q000294:innervation; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007150:Immunohistochemistry; D008099:Liver / Q000098:blood supply; D008156:Luciferases / Q000235:genetics / Q000378:metabolism; D051379:Mice; D009131:Muscle, Smooth, Vascular / Q000254:growth & development* / Q000294:innervation; D032389:Myocytes, Smooth Muscle / Q000187:drug effects / Q000502:physiology*; D018995:Myosin Heavy Chains / Q000235:genetics; D009479:Neuropeptides / Q000494:pharmacology / Q000502:physiology; D011169:Portal Vein / Q000737:chemistry / Q000254:growth & development* / Q000294:innervation; D011401:Promoter Regions, Genetic / Q000235:genetics; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D014162:Transfection
D009479:Neuropeptides; D011993:Recombinant Fusion Proteins; D008156:Luciferases; D018995:Myosin Heavy Chains; D015740:Calcitonin Gene-Related Peptide